AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Sarcoma Metastatic

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125Phase 11 site๐Ÿ“ Chicago Ann & Robert H Lurie Children's Hospital of Chicago ยท Tests: Cytalux A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) NCT07193550Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Zanzalintinib Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC NCT07145450Phase 1, Phase 210 sites๐Ÿ“ Copenhagen๐Ÿ“ Berlin๐Ÿ“ Dresden Anocca AB ยท Tests: ANOC-001 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles), ANOC-002 (TCR-T cells targeting โ€ฆ Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites๐Ÿ“ Fairway๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Metarrestin A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy NCT07633756Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: REC617 A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) โ‰ฅ50% (MK-1084-004/KANDLELIT-004) NCT06345729Phase 3246 sites๐Ÿ“ Bakersfield๐Ÿ“ Beverly Hills๐Ÿ“ Stamford Merck Sharp & Dohme LLC ยท Tests: Calderasib, Placebo, Pembrolizumab Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma NCT04199026NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Doxorubicin, Doxorubicin Hydrochloride, Drug Delivery Microdevice, Everolimus, Ganitumab Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Avapritinib A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma NCT06942442Phase 24 sites๐Ÿ“ Los Angeles๐Ÿ“ Chicago๐Ÿ“ New York Sarcoma Alliance for Research through Collaboration ยท Tests: Physician's Choice, Tebentafusp SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma NCT03138161Phase 1, Phase 21 site๐Ÿ“ Santa Monica Sarcoma Oncology Research Center, LLC ยท Tests: Trabectedin, Ipilimumab, Nivolumab Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma NCT07291297Phase 22 sites๐Ÿ“ Charlotte๐Ÿ“ Winston-Salem Wake Forest University Health Sciences ยท Tests: Metformin Hydrochloride ER First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma NCT06797999Phase 1, Phase 29 sites๐Ÿ“ Aurora๐Ÿ“ Miami๐Ÿ“ New York Adcendo ApS ยท Tests: Antibody-drug conjugate (ADC) A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma NCT05607095Phase 12 sites๐Ÿ“ Harrison๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: Lifileucel (LN-144/LN-145) Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients NCT07642375NA11 sites๐Ÿ“ Athens๐Ÿ“ Athens๐Ÿ“ Athens CareAcross ยท Tests: Digital support Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma NCT06796543NA3 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore๐Ÿ“ Minneapolis Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Consolidative radiation therapy (cRT) IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites๐Ÿ“ St Louis๐Ÿ“ Houston๐Ÿ“ San Antonio ViroMissile, Inc. ยท Tests: IDOV-Immune (oncolytic vaccinia virus) ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer NCT05542407Phase 11 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Atezolizumab, ONC201 Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers NCT05296564Phase 1, Phase 21 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide, HBI 0201-ESO TCRT, Aldesleukin Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions NCT07883798n/a1 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Routine-care metastasis-directed radiotherapy Musculoskeletal Cancers Remote Monitoring and Care NCT07129226NA1 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Smart Watch Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors NCT05868629n/a8 sites๐Ÿ“ Torrance๐Ÿ“ Denver๐Ÿ“ Washington D.C. Novartis Pharmaceuticals ยท Tests: Non-investigational IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Tislelizumab+liposomal doxorubicin+ifosfamide This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY) NCT06805669NA1 site๐Ÿ“ Toronto Mount Sinai Hospital, Canada ยท Tests: Early referral to palliative care, Standard Treatment A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202) NCT07602777Phase 1, Phase 213 sites๐Ÿ“ West Valley City๐Ÿ“ Toronto๐Ÿ“ Montreal GlaxoSmithKline ยท Tests: Ris-Rez, G-CSF Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors NCT07062003NA1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Medical Device Usage and Evaluation, Minibeam Radiation โ€ฆ Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Becotatug Vedotin A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors NCT07229313Phase 17 sites๐Ÿ“ Santa Monica๐Ÿ“ New Have๐Ÿ“ Camperdown Kivu Bioscience Inc. ยท Tests: KIVU-107 VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma NCT07028086Phase 21 site๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: VAM_GROUP Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites๐Ÿ“ Vancouver๐Ÿ“ Toronto British Columbia Cancer Agency ยท Tests: Atezolizumab A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies NCT07613723Phase 12 sites๐Ÿ“ London๐Ÿ“ Manchester Zelluna Immunotherapy AS ยท Tests: ZI-MA4-1 (TCR-NK cells), Cyclophosphamide, Fludarabine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy